N. Irani-Hakime

发表

Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

R. Kreidy, N. Irani-Hakime, N. Irani‐Hakime, 2009, Vascular health and risk management.

Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study.

H. Tamim, N. Irani-Hakime, S. Khoury, 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000.

W. Almawi, H. Tamim, N. Irani-Hakime, 2001, Clinical and laboratory haematology.

Association of Selective HLA Class II Susceptibility-Conferring and Protective Haplotypes with Type 2 Diabetes in Patients from Bahrain and Lebanon

W. Almawi, M. Arekat, N. Irani-Hakime, 2006, Clinical and Vaccine Immunology.

Association of Selective HLA class II Susceptible and Protective Haplotypes with Type 2 Diabetes in Bahrain and Lebanon

W. Almawi, M. Arekat, N. Irani-Hakime, 2006 .

Factor V G1691A (Leiden) and prothrombin G20210A single‐nucleotide polymorphisms in type 2 diabetes mellitus

W. Almawi, G. Timson, N. Irani-Hakime, 2005, American journal of hematology.

Acquired and genetic risk factors for deep vein thrombosis of lower extremities among Lebanese patients.

M. Waked, J. Irani, R. Kreidy, 2012, Le Journal medical libanais. The Lebanese medical journal.

Factor V G1691A, Prothrombin G20210A, and Methylenetetrahydrofolate Reductase [MTHFR] C677T Gene Polymorphism in Angiographically Documented Coronary Artery Disease

W. Almawi, H. Tamim, N. Irani-Hakime, 2004, Journal of Thrombosis and Thrombolysis.

Factor V R506Q Mutation-Leiden: An Independent Risk Factor for Venous Thrombosis but not Coronary Artery Disease

W. Almawi, H. Tamim, R. Kreidy, 2001, Journal of Thrombosis and Thrombolysis.

A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis

Elias A. Rahal, W. Almawi, H. Tamim, 2005, Journal of Thrombosis and Thrombolysis.

The prevalence of factor V R506Q mutation‐Leiden among apparently healthy Lebanese

W. Almawi, H. Tamim, R. Kreidy, 2000, American journal of hematology.

Seroprevalence of hepatitis C infection among health care personnel in Beirut, Lebanon.

H. Tamim, N. Irani-Hakime, S. Khoury, 2001, American journal of infection control.

Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients.

W. Almawi, C. Afif, N. Irani-Hakime, 2003, Transplantation proceedings.

Outbreak of Burkholderia Cepacia Bacteremia Traced to Contaminated Hospital Water Used for Dilution of an Alcohol Skin Antiseptic

W. Almawi, Z. Daoud, A. Rahi, 2004, Infection Control & Hospital Epidemiology.

Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.

A. Motala, W. Almawi, M. Arekat, 2005, The Journal of clinical endocrinology and metabolism.

Proficiency Testing of Therapeutic Drug Monitoring Techniques

W. Almawi, H. Tamim, N. Irani-Hakime, 1999 .

Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Lebanese subjects.

W. Almawi, A. Echtay, R. Nemr, 2012, Diabetes research and clinical practice.

An Arab selective gradient in the distribution of factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T

W. Almawi, T. Mahjoub, N. Fawaz, 2005, Journal of thrombosis and haemostasis : JTH.

Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population

W. Almawi, H. Tamim, N. Irani-Hakime, 2004, American journal of hematology.

Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.

T. Mahjoub, W. Almawi, A. Echtay, 2012, Diabetes & metabolism.

High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean.

W. Almawi, H. Tamim, N. Irani-Hakime, 2000, Clinical chemistry.

The antiproliferative effect of glucocorticoids: is it related to induction of TGF-beta?

N. Irani-Hakime, W. Almawi, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.

W. Almawi, U. Musharrafieh, N. Irani-Hakime, 2006, American journal of infection control.

Strong association of common variants in the IGF2BP2 gene with type 2 diabetes in Lebanese Arabs.

W. Almawi, A. W. Almawi, A. Echtay, 2012, Diabetes research and clinical practice.

Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity

W. Almawi, R. Kreidy, N. Irani-Hakime, 2008, Journal of Thrombosis and Thrombolysis.